Seeking Alpha

AstraZeneca (AZN) and GlaxoSmithKline (GSK) are laying off again - just symptoms of what is a...

AstraZeneca (AZN) and GlaxoSmithKline (GSK) are laying off again - just symptoms of what is a vile start to 2010 for big pharma, says Derek Lowe. And not only aren't industry problems going away, but it looks like new ideas for business models aren't anywhere close, either. (ETFs: IXJ, IYH)
Comments (1)
  • Tom Au, CFA
    , contributor
    Comments (6782) | Send Message
     
    Astra -Zeneca and Glaxo SmithKline aren't among the better managed pharma companies.
    2 Feb 2010, 03:27 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs